430 related articles for article (PubMed ID: 10069646)
21. Homocysteinemia correlates with plasma thiol redox status in patients with end-stage renal disease.
Palleschi S; De Angelis S; Rossi B; Diana L; Papa V; Severini G; Splendiani G
Nephron Clin Pract; 2008; 108(2):c106-12. PubMed ID: 18212512
[TBL] [Abstract][Full Text] [Related]
22. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
23. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
24. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
[TBL] [Abstract][Full Text] [Related]
25. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
[TBL] [Abstract][Full Text] [Related]
26. Treatment of hyperhomocysteinemia in children on dialysis by folic acid.
Schröder CH; de Boer AW; Giesen AM; Monnens LA; Blom H
Pediatr Nephrol; 1999 Sep; 13(7):583-5. PubMed ID: 10460506
[TBL] [Abstract][Full Text] [Related]
27. Hyperhomocysteinemia and oxidative stress in hemodialysis: effects of supplementation with folic acid.
Chiarello PG; Vannucchi MT; Moysés Neto M; Vannucchi H
Int J Vitam Nutr Res; 2003 Nov; 73(6):431-8. PubMed ID: 14743547
[TBL] [Abstract][Full Text] [Related]
28. Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease.
Liu CS; Chiang HC; Chen HW
Nutrition; 2004; 20(11-12):974-8. PubMed ID: 15561486
[TBL] [Abstract][Full Text] [Related]
29. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation.
Huemer M; Ausserer B; Graninger G; Hubmann M; Huemer C; Schlachter K; Tscharre A; Ulmer H; Simma B
Epilepsia; 2005 Oct; 46(10):1677-83. PubMed ID: 16190942
[TBL] [Abstract][Full Text] [Related]
30. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
Righetti M; Serbelloni P; Milani S; Ferrario G
Blood Purif; 2006; 24(4):379-86. PubMed ID: 16755160
[TBL] [Abstract][Full Text] [Related]
31. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
Taes YE; Delanghe JR; De Bacquer D; Langlois M; Stevens L; Geerolf I; Lameire NH; De Vriese AS
Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
[TBL] [Abstract][Full Text] [Related]
32. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
[TBL] [Abstract][Full Text] [Related]
33. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
Lee BJ; Huang MC; Chung LJ; Cheng CH; Lin KL; Su KH; Huang YC
Eur J Clin Nutr; 2004 Mar; 58(3):481-7. PubMed ID: 14985687
[TBL] [Abstract][Full Text] [Related]
34. G1793A polymorphisms in the methylene-tetrahydrofolate gene: effect of folic acid on homocysteine levels.
Melo SS; Persuhn DC; Meirelles MS; Jordao AA; Vannucchi H
Mol Nutr Food Res; 2006 Aug; 50(8):769-74. PubMed ID: 16865747
[TBL] [Abstract][Full Text] [Related]
35. Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India.
Yajnik CS; Lubree HG; Thuse NV; Ramdas LV; Deshpande SS; Deshpande VU; Deshpande JA; Uradey BS; Ganpule AA; Naik SS; Joshi NP; Farrant H; Refsum H
Asia Pac J Clin Nutr; 2007; 16(1):103-9. PubMed ID: 17215186
[TBL] [Abstract][Full Text] [Related]
36. Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.
Miriuka SG; Langman LJ; Keren ES; Miner SE; Mamer OA; Delgado DH; Evrovski J; Ross HJ; Cole DE
J Heart Lung Transplant; 2004 Apr; 23(4):405-12. PubMed ID: 15063399
[TBL] [Abstract][Full Text] [Related]
37. Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy.
van Guldener C; Lambert J; ter Wee PM; Donker AJ; Stehouwer CD
Clin Nephrol; 2000 Jan; 53(1):33-41. PubMed ID: 10661480
[TBL] [Abstract][Full Text] [Related]
38. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
39. Homocysteine, vitamin B12, serum and erythrocyte folate in peritoneal dialysis patients.
De Vecchi AF; Bamonti-Catena F; Finazzi S; Patrosso C; Taioli E; Novembrino C; Colucci P; Lando G; De Franceschi M; Marocchi A; Maiolo AT
Clin Nephrol; 2001 Apr; 55(4):313-7. PubMed ID: 11334318
[TBL] [Abstract][Full Text] [Related]
40. Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease.
Vrentzos GE; Papadakis JA; Vardakis KE; Maliaraki N; Stilianou K; Arvanitis A; Sratigis S; Alivanis P; Margioris AN; Ganotakis ES
J Nephrol; 2003; 16(4):535-9. PubMed ID: 14696755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]